28 results  1 of 2 

1 Overexpression of FRAT1 protein is closely related to triple-negative breast cancer
Sang Eun Nam, Young-Sin Ko, Kyoung Sik Park, TongYi Jin, Young-Bum Yoo, Jung-Hyun Yang, Wook-Youn Kim, Hye-Seung Han, So-Dug Lim, Seung Eun Lee, Wan-Seop Kim
Ann Surg Treat Res.2022;103(2):63-71.   Published online 2022 August 5     DOI: http://dx.doi.org/10.4174/astr.2022.103.2.63
      
2 Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
Soo Youn Bae, Jeong Hyeon Lee, Jeoung Won Bae, Seung Pil Jung
Ann Surg Treat Res.2020;98(6):291-298.   Published online 2020 May 28     DOI: http://dx.doi.org/10.4174/astr.2020.98.6.291
      
3 Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
Chuqian Lei, Ciqiu Yang, Bin Xia, Fei Ji, Yi Zhang, Hongfei Gao, Qianqian Xiong, Yufeng Lin, Xiaosheng Zhuang, Liulu Zhang, Teng Zhu, Minyi Cheng, Mei Yang, Kun Wang
J Breast Cancer.2020;23(1):47-58.   Published online 2020 January 22     DOI: http://dx.doi.org/10.4048/jbc.2020.23.e11
      
4 Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance
Dong Won Baek, Ji-Young Park, Soo Jung Lee, Yee Soo Chae
Yeungnam Univ J Med.2020;37(3):230-235.   Published online 2020 January 22     DOI: http://dx.doi.org/10.12701/yujm.2019.00423
      
5 Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer
Dongmin Kim, Jieun Lee, Jun Kang, Sung Hun Kim, Tae-Kyung Yoo, Sooeun Oh, Ahwon Lee
J Breast Cancer.2019;22(4):562-578.   Published online 2019 December 12     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e56
      
6 Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, Tim J Price, Amanda R Townsend
J Breast Cancer.2019;22(3):341-361.   Published online 2019 September 2     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e39
      
7 High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma
Chun-Tao Shi, Jun Ma, Qi-Feng Shi, Ye Zhang, Hao-Nan Wang
J Breast Cancer.2019;22(2):248-259.   Published online 2019 April 19     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e20
      
8 ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line
Eunjoo Hwang, Seong-Hye Hwang, Jongjin Kim, Jin Hyun Park, Sohee Oh, Young A Kim, Ki-Tae Hwang
Ann Surg Treat Res.2018;95(5):240-248.   Published online 2018 October 25     DOI: http://dx.doi.org/10.4174/astr.2018.95.5.240
      
9 High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy
Bobae Shim, Min-Sun Jin, Ji Hye Moon, In Ae Park, Han Suk Ryu
J Pathol Transl Med.2018;52(6):369-377.   Published online 2018 October 1     DOI: http://dx.doi.org/10.4132/jptm.2018.09.19
      
10 The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
Daiana Cosmina Temian, Laura Ancuta Pop, Alexandra Iulia Irimie, Ioana Berindan-Neagoe
J Breast Cancer.2018;21(3):233-243.   Published online 2018 September 20     DOI: http://dx.doi.org/10.4048/jbc.2018.21.e41
      
11 Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo
Yu Wei Deng, Wen Jing Hao, Yi Wen Li, Yi Xin Li, Bo Chen Zhao, Dan Lu
J Breast Cancer.2018;21(3):251-258.   Published online 2018 September 12     DOI: http://dx.doi.org/10.4048/jbc.2018.21.e40
      
12 Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer
Yunxuan Wang, Tieying Dong, Qijia Xuan, Hong Zhao, Ling Qin, Qingyuan Zhang
J Breast Cancer.2018;21(2):124-133.   Published online 2018 June 20     DOI: http://dx.doi.org/10.4048/jbc.2018.21.2.124
      
13 Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer
Man Li, Yang Wang, Feng Wei, Xiumei An, Naining Zhang, Shui Cao, Baozhu Ren, Xinwei Zhang, Xiubao Ren
J Breast Cancer.2018;21(2):150-157.   Published online 2018 June 20     DOI: http://dx.doi.org/10.4048/jbc.2018.21.2.150
      
14 Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
Milim Kim, Hyun Jeong Kim, Yul Ri Chung, Eunyoung Kang, Eun-Kyu Kim, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park
J Breast Cancer.2018;21(2):197-205.   Published online 2018 June 20     DOI: http://dx.doi.org/10.4048/jbc.2018.21.2.197
      
15 Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23
Kyubo Kim, Hae Jin Park, Kyung Hwan Shin, Jin Ho Kim, Doo Ho Choi, Won Park, Seung Do Ahn, Su Ssan Kim, Dae Yong Kim, Tae Hyun Kim, Jin Hee Kim, Jiyoung Kim
Cancer Res Treat.2018;50(4):1316-1323.   Published online 2018 January 8     DOI: http://dx.doi.org/10.4143/crt.2017.575
      
16 Gene Regulatory Network Analysis for Triple-Negative Breast Neoplasms by Using Gene Expression Data
Hee Chan Jung, Sung Hwan Kim, Jeong Hoon Lee, Ju Han Kim, Sung Won Han
J Breast Cancer.2017;20(3):240-245.   Published online 2017 September 22     DOI: http://dx.doi.org/10.4048/jbc.2017.20.3.240
      
17 Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
Aeri Kim, Min Hye Jang, Soo Jung Lee, Young Kyung Bae
J Breast Cancer.2017;20(2):150-159.   Published online 2017 June 26     DOI: http://dx.doi.org/10.4048/jbc.2017.20.2.150
      
18 Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer
Ki-Tae Hwang, Wonshik Han, Jongjin Kim, Hyeong-Gon Moon, Sohee Oh, Yun Seon Song, Young A Kim, Mee Soo Chang, Dong-Young Noh
J Breast Cancer.2017;20(1):54-64.   Published online 2017 March 24     DOI: http://dx.doi.org/10.4048/jbc.2017.20.1.54
      
19 A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
Jeanny Kwon, Keun-Yong Eom, Tae Ryool Koo, Byoung Hyuck Kim, Eunyoung Kang, Sung-Won Kim, Yu Jung Kim, So Yeon Park, In Ah Kim
J Breast Cancer.2017;20(1):65-73.   Published online 2017 March 24     DOI: http://dx.doi.org/10.4048/jbc.2017.20.1.65
      
20 Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells
Anil Badana, Madhuri Chintala, Gayathri Varikuti, Nagaseshu Pudi, Seema Kumari, Vijaya Rachel Kappala, Rama Rao Malla
J Breast Cancer.2016;19(4):372-384.   Published online 2016 December 23     DOI: http://dx.doi.org/10.4048/jbc.2016.19.4.372
      

 1 of 2